Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...
LONDON/COPENHAGEN (Reuters) -Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled ...
LAURA CRAIK looks into a new trend where designer brands are turning commonplace items into designer must-haves by slapping a ...
Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...
Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...
Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
Participants in the trend used an AI-driven tool, created by a user on the editing app CapCut, to alter themselves to look ...
Schumer said she was having success on Mounjaro after previously being unable to "handle" Ozempic's side effects.
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
1 National University of Singapore Centre for Biomedical Ethics, Singapore 2 Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Semaglutide, ...
“I sent letters to those grantees defunding them. We are going to be slimming this agency down drastically—like it’s on an Ozempic diet.” The White House, late on March 14, released the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results